A Prognostic Scoring System for Predicting Overall Survival of Patients with the TNM 8th Edition Stage I and II Hepatocellular Carcinoma After Surgery: A Population-Based Study

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314. doi:10.1016/S0140-6736(18)30010-229307467
   PubMed Web of Science ®Google Scholar
• Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(03):329–338. doi:10.1055/s-2007-100712210518312
   PubMed Web of Science ®Google Scholar
• Kudo M, Chung H, Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol. 2003;38(3):207–215. doi:10.1007/s00535030003812673442
   PubMed Web of Science ®Google Scholar
• Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg. 2007;245(6):909–922. doi:10.1097/01.sla.0000254368.65878.da17522517
   PubMed Web of Science ®Google Scholar
• Farinati F, Vitale A, Spolverato G, et al. Development and validation of a new prognostic system for patients with hepatocellular carcinoma. PLoS Med. 2016;13(4):e1002006. doi:10.1371/journal.pmed.100200627116206
   PubMed Web of Science ®Google Scholar
• Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–99. doi:10.3322/caac.2138828094848
   PubMed Web of Science ®Google Scholar
• Chun YH, Kim SU, Park JY, et al. Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma. Eur J Cancer. 2011;47(17):2568–2575. doi:10.1016/j.ejca.2011.07.00221835608
   PubMed Web of Science ®Google Scholar
• Huang J, Zhang Y, Peng Z, et al. A modified TNM-7 staging system to better predict the survival in patients with hepatocellular carcinoma after hepatectomy. J Cancer Res Clin Oncol. 2013;139(10):1709–1719. doi:10.1007/s00432-013-1497-y23982274
   PubMed Web of Science ®Google Scholar
• Kamarajah SK, Frankel TL, Sonnenday C, Cho CS, Nathan H. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): a Surveillance, Epidemiology, End Results (SEER) analysis. J Surg Oncol. 2018;117(4):644–650. doi:10.1002/jso.2490829127719
   PubMed Web of Science ®Google Scholar
• Cho CS, Gonen M, Shia J, et al. A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma. J Am Coll Surg. 2008;206(2):281–291. doi:10.1016/j.jamcollsurg.2007.07.03118222381
   PubMed Web of Science ®Google Scholar
• Xu L, Peng ZW, Chen MS, et al. Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. J Hepatol. 2015;63(1):122–130. doi:10.1016/j.jhep.2015.02.03425725438
   PubMed Web of Science ®Google Scholar
• Shim JH, Jun MJ, Han S, et al. Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma. Ann Surg. 2015;261(5):939–946. doi:10.1097/SLA.000000000000074724950276
   PubMed Web of Science ®Google Scholar
• Yang P, Qiu J, Li J, et al. Nomograms for pre- and postoperative prediction of long-term survival for patients who underwent hepatectomy for multiple hepatocellular carcinomas. Ann Surg. 2016;263(4):778–786. doi:10.1097/SLA.000000000000133926135698
   PubMed Web of Science ®Google Scholar
• He W, Peng B, Tang Y, et al. Nomogram to predict survival of patients with recurrence of hepatocellular carcinoma after surgery. Clin Gastroenterol Hepatol. 2018;16(5):756–764 e710. doi:10.1016/j.cgh.2017.12.00229246702
   PubMed Web of Science ®Google Scholar
• Zhang XP, Gao YZ, Chen ZH, et al. An eastern hepatobiliary surgery hospital/portal vein tumor thrombus scoring system as an aid to decision making on hepatectomy for hepatocellular carcinoma patients with portal vein tumor thrombus: a multicenter study. Hepatology. 2018. doi:10.1002/hep.30490
   Web of Science ®Google Scholar
• Xiao Z, Yan Y, Zhou Q, et al. Development and external validation of prognostic nomograms in hepatocellular carcinoma patients: a population based study. Cancer Manag Res. 2019;11:2691–2708. doi:10.2147/CMAR.S19128731118768
   PubMed Web of Science ®Google Scholar
• Marasco G, Colecchia A, Colli A, et al. Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection. J Hepatol. 2019;70(3):440–448. doi:10.1016/j.jhep.2018.10.02230389551
   PubMed Web of Science ®Google Scholar
• Liu GM, Zeng HD, Zhang CY, Xu JW. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma. Cancer Cell Int. 2019;19(1):138. doi:10.1186/s12935-019-0858-231139015
   PubMed Web of Science ®Google Scholar
• Qiu J, Peng B, Tang Y, et al. CpG methylation signature predicts recurrence in early-stage hepatocellular carcinoma: results from a multicenter study. J Clin Oncol. 2017;35(7):734–742. doi:10.1200/JCO.2016.68.215328068175
   PubMed Web of Science ®Google Scholar
• Dong W, Yu H, Zhu YY, et al. A novel pathological scoring system for hepatic cirrhosis with hepatocellular carcinoma. Cancer Manag Res. 2020;12:5537–5547. doi:10.2147/CMAR.S22341732753967
   PubMed Web of Science ®Google Scholar
• Zhou TH, Su JZ, Qin R, Chen X, Ju GD, Miao S. Prognostic and predictive value of a 15 Transcription Factors (TFs) panel for hepatocellular carcinoma. Cancer Manag Res. 2020;12:12349–12361. doi:10.2147/CMAR.S27919433293862
   PubMed Web of Science ®Google Scholar
• Berardi G, Morise Z, Sposito C, et al. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis. J Hepatol. 2020;72(1):75–84. doi:10.1016/j.jhep.2019.08.03231499131
   PubMed Web of Science ®Google Scholar
• Wang YY, Xiang BD, Ma L, et al. Development and validation of a nomogram to preoperatively estimate post-hepatectomy liver dysfunction risk and long-term survival in patients with hepatocellular carcinoma. Ann Surg. 2020;Publish Ahead of Print. doi:10.1097/SLA.0000000000004407
   Google Scholar
• Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10(1):35–43. doi:10.1016/S1470-2045(08)70284-519058754
   PubMed Web of Science ®Google Scholar
• Compton CC, Byrd DR, Garcia-Aguilar J, Kurtzman SH, Olawaiye A, Washington MK. Liver. In: Compton CC, Byrd DR, Garcia-Aguilar J, Kurtzman SH, Olawaiye A, Washington MK, editors. AJCC Cancer Staging Atlas: A Companion to the Seventh Editions of the AJCC Cancer Staging Manual and Handbook. New York: Springer New York; 2012:241–249.
   Google Scholar
• Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565–574. doi:10.1177/0272989X0629536117099194
   PubMed Web of Science ®Google Scholar
• Zhang Z, Rousson V, Lee WC, et al. Decision curve analysis: a technical note. Ann Transl Med. 2018;6(15):308. doi:10.21037/atm.2018.07.0230211196
   PubMed Web of Science ®Google Scholar
• Liu T, Lin SW, Lin S, et al. Exploration of high-risk factors for pulmonary embolism in patients undergoing postoperative anti-thrombotic therapy among gynecologic oncology surgery: a retrospective study. Ann Transl Med. 2019;7(7):143. doi:10.21037/atm.2019.03.0731157264
   PubMed Web of Science ®Google Scholar
• Chun YS, Pawlik TM, Vauthey JN. 8th edition of the AJCC cancer staging manual: pancreas and hepatobiliary cancers. Ann Surg Oncol. 2018;25(4):845–847. doi:10.1245/s10434-017-6025-x28752469
   PubMed Web of Science ®Google Scholar
• Li HB, Zhao FQ, Zhou J. Prognostic nomogram for disease-specific survival in patients with non-metastatic ampullary carcinoma after surgery. Ann Surg Oncol. 2019;26(4):1079–1085. doi:10.1245/s10434-018-07115-830659390
   PubMed Web of Science ®Google Scholar
• Burkhart RA, Pawlik TM. Staging and prognostic models for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Control. 2017;24(3):1073274817729235. doi:10.1177/107327481772923528975828
   PubMed Web of Science ®Google Scholar
• Roayaie S, Obeidat K, Sposito C, et al. Resection of hepatocellular cancer. Hepatology. 2013;57(4):1426–1435. doi:10.1002/hep.2583222576353
   PubMed Web of Science ®Google Scholar
• Hwang S, Lee YJ, Kim KH, et al. The impact of tumor size on long-term survival outcomes after resection of solitary hepatocellular carcinoma: single-institution experience with 2558 patients. J Gastrointest Surg. 2015;19(7):1281–1290. doi:10.1007/s11605-015-2849-525956724
   PubMed Web of Science ®Google Scholar
• Nathan H, Hyder O, Mayo SC, et al. Surgical therapy for early hepatocellular carcinoma in the modern era: a 10-year SEER-medicare analysis. Ann Surg. 2013;258(6):1022–1027. doi:10.1097/SLA.0b013e31827da74923299519
   PubMed Web of Science ®Google Scholar
• Guerrini GP, Pinelli D, Di Benedetto F, et al. Predictive value of nodule size and differentiation in HCC recurrence after liver transplantation. Surg Oncol. 2016;25(4):419–428. doi:10.1016/j.suronc.2015.09.00326403621
   PubMed Web of Science ®Google Scholar
• Pote N, Cauchy F, Albuquerque M, et al. Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion. J Hepatol. 2015;62(4):848–854. doi:10.1016/j.jhep.2014.11.00525450201
   PubMed Web of Science ®Google Scholar
• Wang YY, Zhong JH, Xu HF, et al. A modified staging of early and intermediate hepatocellular carcinoma based on single tumour >7 cm and multiple tumours beyond up-to-seven criteria. Aliment Pharmacol Ther. 2019;49(2):202–210. doi:10.1111/apt.1507430506713
   PubMed Web of Science ®Google Scholar
• Gray SH, White JA, Li P, et al. A SEER database analysis of the survival advantage of transarterial chemoembolization for hepatocellular carcinoma: an underutilized therapy. J Vasc Interv Radiol. 2017;28(2):231–237 e232. doi:10.1016/j.jvir.2016.09.02227939085
   PubMed Web of Science ®Google Scholar